• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降钙素受体基因在K562慢性髓性白血病细胞中的表达。

Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells.

作者信息

Mould Richard, Pondel Marc D

机构信息

St, George's Hospital Medical School Dept, of Cellular Pathology London, SW17 ORE, United Kingdom.

出版信息

Cancer Cell Int. 2003 Apr 25;3(1):6. doi: 10.1186/1475-2867-3-6.

DOI:10.1186/1475-2867-3-6
PMID:12747809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC155681/
Abstract

BACKGROUND

The peptide hormone calcitonin (CT) can significantly effect the proliferation rate of CT receptor (CTR) positive human cancer cells. We wish to identify additional human cancers expressing CTRs and assay the effects of CT on their growth rates and signal transduction pathways. RESULTS: The expression of the human calcitonin receptor (hCTR) gene in the chronic myelogenous leukemia cell line K562 was examined. RT-PCR on total RNA extracted from K562 cells detected the presence of hCTR mRNA. Further analysis demonstrated that multiple hCTR isoforms were present. Incubation of K562 cells with salmon calcitonin (sCT), but not amylin, caused an increase in intracellular levels of cAMP similar to that induced by forskolin treatment. We further demonstrated that butyrate induced erythroid differentiation of K562 cells caused a significant decrease in hCTR mRNA levels. However, phorbol myristate acetate (PMA) induced megakaryocytic differentiation of these cells had no significant effect on hCTR mRNA levels. We demonstrated that exposure to various concentrations of sCT had no effect on the cellular proliferation of K562 cells in vitro. CONCLUSION: Chronic myelogenous k562 cells express multiple CTR isoforms. However, CT does not effect K562 proliferation rates. It is likely that the small increase in intracellular levels of cAMP following CT treatment is not sufficient to interfere with cellular growth.

摘要

背景

肽激素降钙素(CT)可显著影响降钙素受体(CTR)阳性人类癌细胞的增殖速率。我们希望鉴定出其他表达CTR的人类癌症,并检测CT对其生长速率和信号转导途径的影响。结果:检测了慢性髓性白血病细胞系K562中人降钙素受体(hCTR)基因的表达。对从K562细胞中提取的总RNA进行逆转录聚合酶链反应(RT-PCR),检测到hCTR mRNA的存在。进一步分析表明存在多种hCTR亚型。用鲑鱼降钙素(sCT)而非胰淀素孵育K562细胞,导致细胞内cAMP水平升高,类似于福司可林处理诱导的升高。我们进一步证明,丁酸盐诱导K562细胞向红系分化导致hCTR mRNA水平显著降低。然而,佛波酯肉豆蔻酸酯(PMA)诱导这些细胞向巨核系分化对hCTR mRNA水平没有显著影响。我们证明,暴露于不同浓度的sCT对体外K562细胞的增殖没有影响。结论:慢性髓性K562细胞表达多种CTR亚型。然而,CT不影响K562的增殖速率。CT处理后细胞内cAMP水平的小幅升高可能不足以干扰细胞生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/645fa2d4fe45/1475-2867-3-6-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/aa8b19b2467a/1475-2867-3-6-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/0adc3827ad96/1475-2867-3-6-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/f31e81a62157/1475-2867-3-6-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/fee5c534d915/1475-2867-3-6-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/645fa2d4fe45/1475-2867-3-6-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/aa8b19b2467a/1475-2867-3-6-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/0adc3827ad96/1475-2867-3-6-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/f31e81a62157/1475-2867-3-6-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/fee5c534d915/1475-2867-3-6-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c3/155681/645fa2d4fe45/1475-2867-3-6-5.jpg

相似文献

1
Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells.降钙素受体基因在K562慢性髓性白血病细胞中的表达。
Cancer Cell Int. 2003 Apr 25;3(1):6. doi: 10.1186/1475-2867-3-6.
2
Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.从骨巨细胞瘤中克隆出的两种人骨骼降钙素受体亚型的表达。第一个细胞内结构域调节配体结合和信号转导。
J Clin Invest. 1995 Jun;95(6):2680-91. doi: 10.1172/JCI117970.
3
Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes.人降钙素受体细胞内环1对肌醇磷酸第二信使形成的抑制作用。合成受体基因的表达及突变分析
J Biol Chem. 1994 Nov 11;269(45):28123-9.
4
Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.源自人降钙素受体/RAMP共表达的胰淀素受体表型表现出取决于受体亚型和宿主细胞环境的药理学差异。
J Pharmacol Exp Ther. 2000 Jul;294(1):61-72.
5
Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptor.人降钙素受体插入缺失型而非插入阳性型持续激活Erk1/2丝裂原活化蛋白激酶并抑制细胞生长。
J Endocrinol. 2000 Oct;167(1):93-105. doi: 10.1677/joe.0.1670093.
6
Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line.来自卵巢癌细胞系的人降钙素受体的克隆、特性鉴定及表达
J Clin Invest. 1992 Nov;90(5):1726-35. doi: 10.1172/JCI116046.
7
Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites.嵌合型人降钙素受体和胰高血糖素受体揭示了两个可分离的降钙素相互作用位点。
Biochemistry. 1995 Jan 24;34(3):1050-7. doi: 10.1021/bi00003a040.
8
Nerve growth factor potentiated the sodium butyrate- and PMA-induced megakaryocytic differentiation of K562 leukemia cells.神经生长因子增强了丁酸钠和佛波酯诱导的K562白血病细胞向巨核细胞的分化。
Leuk Res. 2000 Sep;24(9):751-9. doi: 10.1016/s0145-2126(00)00044-8.
9
Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells.牛可透析白细胞提取物对K562人慢性粒细胞白血病细胞诱导细胞分化和死亡的影响。
Oncol Lett. 2016 Dec;12(6):4449-4460. doi: 10.3892/ol.2016.5285. Epub 2016 Oct 18.
10
Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.在体外使用核因子κB受体激活剂配体和巨噬细胞集落刺激因子制备的人破骨细胞样细胞中降钙素受体的调节及对降钙素的反应性
Endocrinology. 2000 Oct;141(10):3774-82. doi: 10.1210/endo.141.10.7715.

引用本文的文献

1
Building the case for the calcitonin receptor as a viable target for the treatment of glioblastoma.确立降钙素受体作为治疗胶质母细胞瘤的可行靶点的依据。
Ther Adv Med Oncol. 2020 Dec 18;12:1758835920978110. doi: 10.1177/1758835920978110. eCollection 2020.
2
Cloning and expression of the functional human anti-vascular endothelial growth factor (VEGF) using the pcDNA3.1 vector and the human chronic myelogenous leukemia cell line K562.使用 pcDNA3.1 载体和人慢性髓系白血病细胞系 K562 克隆和表达功能型人抗血管内皮生长因子(VEGF)。
Protein J. 2014 Feb;33(1):100-9. doi: 10.1007/s10930-013-9533-y.
3
The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaque.

本文引用的文献

1
Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium.降钙素的证据——一种来自甲状旁腺的新激素,可降低血钙水平。
Endocrinology. 1962 May;70:638-49. doi: 10.1210/endo-70-5-638.
2
Transgenic mice reveal novel sites of calcitonin receptor gene expression during development.转基因小鼠揭示了降钙素受体基因在发育过程中的新表达位点。
Biochem Biophys Res Commun. 2000 Jul 21;274(1):124-9. doi: 10.1006/bbrc.2000.3093.
3
Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha.
降钙素受体在募集到动脉粥样硬化斑块内皮层和新生内膜中的细胞上表达升高。
Histochem Cell Biol. 2009 Aug;132(2):181-9. doi: 10.1007/s00418-009-0600-6. Epub 2009 Apr 29.
4
Cloning and transcriptional analysis of the mouse receptor activity modifying protein-1 gene promoter.小鼠受体活性修饰蛋白-1基因启动子的克隆与转录分析
BMC Mol Biol. 2005 Mar 24;6:7. doi: 10.1186/1471-2199-6-7.
环磷酸腺苷(cAMP)依赖性蛋白激酶活性的组成水平决定了人多药耐药白血病细胞系对福斯高林和肿瘤坏死因子α诱导的生长抑制和凋亡的敏感性。
Br J Haematol. 2000 Mar;108(3):565-73. doi: 10.1046/j.1365-2141.2000.01903.x.
4
Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.多种胰淀素受体源于受体活性修饰蛋白与降钙素受体基因产物的相互作用。
Mol Pharmacol. 1999 Jul;56(1):235-42. doi: 10.1124/mol.56.1.235.
5
Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers.降钙素受体、骨唾液蛋白和骨桥蛋白在原发性乳腺癌中表达。
Int J Cancer. 1997 Dec 10;73(6):812-5. doi: 10.1002/(sici)1097-0215(19971210)73:6<812::aid-ijc7>3.0.co;2-5.
6
Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.垂体腺苷酸环化酶激活多肽I型受体的分子克隆与功能表达
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6345-9. doi: 10.1073/pnas.90.13.6345.
7
Expression cloning and signaling properties of the rat glucagon receptor.大鼠胰高血糖素受体的表达克隆及信号传导特性
Science. 1993 Mar 12;259(5101):1614-6. doi: 10.1126/science.8384375.
8
Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients.降钙素通过受体介导增加环磷酸腺苷和细胞质钙离子瞬变来刺激人前列腺癌细胞的生长。
Endocrinology. 1994 Feb;134(2):596-602. doi: 10.1210/endo.134.2.8299557.
9
Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.胃抑制性多肽受体是促胰液素-血管活性肠肽受体家族的成员之一,广泛分布于外周器官和大脑中。
Endocrinology. 1993 Dec;133(6):2861-70. doi: 10.1210/endo.133.6.8243312.
10
A new type of human calcitonin receptor isoform generated by alternative splicing.一种通过可变剪接产生的新型人降钙素受体亚型。
Biochem Biophys Res Commun. 1995 Apr 17;209(2):744-51. doi: 10.1006/bbrc.1995.1562.